Volume 18, Issue 2 pp. 147-148
Communication
Full Access

Synthesis of the Mast Cell Degranulating (MCD) Peptide from Bee Venom

Priv.-Doz. Dr. Christian Birr

Corresponding Author

Priv.-Doz. Dr. Christian Birr

Max-Planck-Institut für Medizinische Forschung, Abteilung Naturstoff-Chemie, Jahnstrasse 29, D-6900 Heidelberg 1 (Germany)

Max-Planck-Institut für Medizinische Forschung, Abteilung Naturstoff-Chemie, Jahnstrasse 29, D-6900 Heidelberg 1 (Germany)Search for more papers by this author
Dr. Margot Wengert-Müller

Dr. Margot Wengert-Müller

Max-Planck-Institut für Medizinische Forschung, Abteilung Naturstoff-Chemie, Jahnstrasse 29, D-6900 Heidelberg 1 (Germany)

Search for more papers by this author
First published: February 1979
Citations: 6

Ch. Birr, Lecture at German-Soviet Peptide Symposium, Eibsee 1978.—We are grateful to Prof. Dr. E. Habermann. Giessen, for a sample of MCD peptide.

Abstract

Potential value in the therapy of rheumatism and other inflammation processes could attach to the MCD peptide from bee venom if it were available in larger quantities. The peptide consists of 22 amino acids and contains two disulfide bridges. Its first total synthesis has now been accomplished.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.